Shezad Malik Law Firm Dr Shezad Malik Law Firm has offices based in Fort Worth and Dallas and represents people who have suffered catastrophic and serious personal injuries including wrongful death, caused by the negligence or recklessness of others. We specialize in Personal Injury trial litigation and focus our energy and efforts on those we represent.

Risperdal Male Breast Growth Lawsuit

Multiple lawsuits have been filed in the United States against the makers of Risperdal for failing to warn patients that it may cause male breast growth, a condition known as Gynecomastia.

Risperdal Male Breast Growth Lawsuit

Risperdal lawsuits increase in U.S.

Risperdal was approved for sale in the United States in 1993 by the Food and Drug Administration (FDA). It commonly used to treat irritability in people with autism, schizophrenia, and bipolar disorder.

The makers of Risperdal began marketing the drug to treat children as early as 2003, years before the FDA approved such action by the drug-maker. The makers of Risperdal also recently faced accusations that it was paying physicians to speak favorably of the drug, sponsor golf outings, and offering other incentives encouraging doctors to prescribe Risperdal to adolescents and children.

Kentucky attorney general filed a lawsuit against the manufacturer in 2012 alleging that they concealed dangerous side effects including substantial weight gain, diabetes, stroke, and male breast growth.

Last year a jury decided the makers of Risperdal must pay $2.5 million for failing to warn that Risperdal may cause abnormal breast growth in males. The lawsuit was launched by the family of an autistic boy who took the drug and later developed 46DD breasts.

The 2015 lawsuit was the first Risperdal lawsuit claiming the manufacturer hid the risks of male breast growth to go to trial. Previous lawsuits were settled out of court. Former FDA commissioner David Kessler testified at the trial that the manufacturer knew about the risks of male breast growth but failed to disclose the information. In a 2012 report, Kessler wrote the manufacturer of Risperdal had violated the law.

Abnormal male breast growth is a condition known as Gynecomastia. It is a swelling of the breast tissue in men or boys caused by an imbalance of the hormones testosterone and estrogen. Abnormal male breast growth can affect one or both breast, sometimes unevenly. In some rare cases the condition could lead to nipple discharge in one or both breasts.

Have you been diagnosed with Gynecomastia or have had abnor after taking Risperdal?

Contact Information